LEO 22811
/ LEO Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 12, 2011
A proof of concept study comparing three doses of an oral solution of LEO 22811 with a placebo oral solution for the treatment of psoriasis vulgaris
(clinicaltrials.gov)
- P2, N=63; Recruiting → Completed
Trial completion • Psoriasis
1 to 1
Of
1
Go to page
1